What You Should Know:
- Teladoc Health recently added an at-home A1C testing program to its chronic care solution, making it easier for members to manage their diabetes while also bridging health equity gaps in chronic condition care.
- Livongo by Teladoc Health members will have the option to receive at-home A1C tests provided by LetsGetChecked, a leading healthcare solutions company that enables providers to administer diagnostics and
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Analysis: 2022 Semi-Annual Health IT Market Review
Executive Summary
Act III of COVID: Navigating the Crosscurrents of Post-Inflation
2022 ushered in Act III of the market’s latest transitionary period: The Post-Inflation Era. Since 2008, the US economy functioned with remarkably low inflation and interest rates. As the cost of capital went lower and lower during the decade, valuations steadily rose. Between 2010 and 2020, the NASDAQ experienced a 17.1% annual growth rate, with no small share of the growth a result of expanding valuation
Read More
Glooko Launches Diabetes Medical Education Academy in Ireland
What You Should Know:
- Glooko announced, in partnership with the Diabetes Technology Network (DTN)/Association of British Clinical Diabetologists (ABCD), the expansion into Ireland of Academy, the company’s online medical education program for clinicians who treat people with diabetes.
- Originally inspired after discussions with the National Health Service England (NHSE) as part of its effort to ensure all healthcare professionals learn uniformly about technology, the program will help
Read More
At-Home Digital Health Innovations Transforming Diabetes Care
If you’re looking for a silver lining in the COVID-19 dark cloud still enshrouding the world, consider this: The pandemic has turbocharged widespread acceptance of at-home digital health solutions. Forced to function in a world of social distancing, healthcare providers and physicians have quickly discovered how easily telehealth visits, remote patient monitoring (RPM) and digital therapeutics can improve patient care.
Many of these digital health innovations are designed to address
Read More
9am.health, Ascensia Partner to Expand Virtual Diabetes Clinic
What You Should Know:
- 9am.health today announced it is expanding its virtual diabetes clinic through a strategic partnership with Ascensia to add the CONTOUR®NEXT ONE Blood Glucose Meter to Its patient toolkit.
- 9am.health patients can now conveniently add Ascensia Diabetes Care’s blood glucose meter and test strips to their personalized treatment plan, with the meter offered free of charge to all patient care plans. The test strip add-on is available through a
Read More
Early Use of Diabetes Technology Drives Better Patient Outcomes in Kids
A recent study from Stanford found that pediatric patients with rapid access to continuous glucose monitoring soon after a type 1 diabetes diagnosis had healthier blood sugar values than an earlier group of patients who weren’t given the monitors near the time of diagnosis.
The research provides an example of how the healthcare industry is evolving to use technology: It provides more frequent touchpoints with caregivers, makes quality care available to a larger number of patients, and
Read More
Carbon Health Acquires CGM-Enabled Virtual Diabetes Platform Steady Health
What You Should Know:
- Carbon Health, a technology-enabled healthcare provider, announced the acquisition of Steady Health, a fully integrated diabetes platform that uses data from continuous glucose monitoring (CGM) devices to provide personalized medical care from top endocrinologists. Financial details of the acquisition were not disclosed.
- The Steady Health acquisition accelerates Carbon Health’s rollout of an innovative new primary care model, which integrates Carbon Health’s
Read More
Glooko Integrates with Eli Lilly’s Connected Insulin Pen Solutions in Global Markets
What We Should Know:
- Glooko Inc., a provider of remote patient monitoring and data management solutions for diabetes and other chronic conditions announced a strategic collaboration with Eli Lilly and Company for people with diabetes that use Lilly’s connected insulin pen solutions.
- The technology collaboration will ease insulin management for people with diabetes and their healthcare providers in markets outside the U.S., via integration of Lilly’s Tempo Pen™ and
Read More
Medtronic Launches Initiatives to Address Health Equity for People of Color Living with Diabetes
What You Should Know:
- Medtronic announced its ongoing commitment to health equity for people of color living with diabetes. The company committed investments in partnerships with the American Diabetes Association® (ADA) and T1D Exchange, as well as additional research efforts, to better understand and address these disparities.
New Partnerships and Research Efforts Prioritized Over the Next Three Years to Address Health Disparities
Details of each partnership, as well as additional
Read More
Glooko Raises $30M to Expand Digital Diabetes Management Platform
What You Should Know:
- Glooko, a Palo Alto, CA-based provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, today announced that they have raised a $30 million Series D round of funding. The funding was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic.
- Glooko plans to use these proceeds from this funding to accelerate organic growth and
Read More
